I'm not so sure. There is something stopping him

I'm not so sure. There is something stopping him from funding the $500K bridge that SeD Biomedical is considering putting into AMBS. It bugs me that he won't follow through on that.

Funding that would give us enough money to get us back into SEC compliance and out of the OTC doghouse.

Quote:

---

I think either the noteholders have agreed to the new "strategic measures" that SeD required (maybe even the formation of these subsidiaries are part of those measures) or at the very least SeD is confident that they have an agreement.

There is no way I see them investing another $100k into the company and going to the trouble of creating these subsidiaries without a plan worked out and agreed upon. Even though they could convert the $100k loan to shares in the event the toxics walked, they wouldn't be continuing to move forward at this point because they would lose leverage to negotiate by doing so. They would have stopped and said, we're not doing anything until everyone has agreed, but they are moving forward.

---